| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |